Sign in
4

Changes in Ownership

TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-22-014475

Exec. VP Chief Legal Officer sold 6,452 shares at $8.14 ($52,533)

  • Exec. VP Chief Legal Officer acquired 18,430 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Stark David Matthew · Exec. VP Chief Legal Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-02-28 Exercise or conversion : show line 1 in the form +18,430 27,832.39 D
2022-02-28 Sale : show line 2 in the form −6,452 $8.14 $52,533 21,380.39 D
Open-market sales · 6,452 sh · avg $8.14 · $52,533

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-02-28 Exercise or conversion : show line 3 in the form Restricted Share Units −18,430 36,860 D
Loading xslF345X03/doc4.xml…